Skip to search formSkip to main contentSkip to account menu

pneumococcal conjugate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
One-Step Multiplex PCR Assay for Detecting Streptococcus pneumoniae Serogroups/Types Covered by 13-Valent Pneumococcal Conjugate Vaccine (PCV13)
The life-threatening illnesses caused by Streptococcus pneumoniae have been declined significantly after the use of pneumococcal… 
2010
2010
Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapy
Objective:Vaccination responses may be affected by concomitant use of highly active antiretroviral therapy (HAART). We aimed to… 
Review
2008
Review
2008
Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data.
A 7-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV7) was licensed in the United States of America in 2000, but… 
Review
2008
Review
2008
Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
2006
2006
Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: Theoretical coverage of the 7‐valent and 9‐valent pneumococcal conjugate vaccines
Although the causative pneumococcal serotypes of invasive diseases are already extensively studied, few data are available about… 
Review
2004
Review
2004
The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis media
Purpose of reviewThis review provides the otolaryngologist with the evolving understanding of various aspects of pneumococcal… 
2004
2004
Serotypes and Sequence Types of Pneumococci Causing Invasive Disease in Scotland Prior to the Introduction of Pneumococcal Conjugate Polysaccharide Vaccines
ABSTRACT Pneumococcal conjugate polysaccharide (Pnc) vaccines are now available, and the need for an improved understanding of… 
2001
2001
Activation of Cell‐Mediated Immunity Following Immunization with Pneumococcal Conjugate or Polysaccharide Vaccine *
The immunogenicity of pneumococcal polysaccharide (PS) vaccines can be improved by conjugating PS to a polypeptide carrier that… 
Highly Cited
2000
Highly Cited
2000
Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes.
Conjugate vaccines against Streptococcus pneumoniae (pneumococcus) protect against nasopharyngeal carriage of serotypes included… 
Highly Cited
1999
Highly Cited
1999
B- and T-Cell Immune Responses to Pneumococcal Conjugate Vaccines: Divergence between Carrier- and Polysaccharide-Specific Immunogenicity
ABSTRACT Conjugation of various serotypes of pneumococcal polysaccharide (PnPS) to carrier protein enhances the magnitude of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)